Lisa Utzschneider Sells 30,407 Shares of Integral Ad Science Holding Corp. (NASDAQ:IAS) Stock

Integral Ad Science Holding Corp. (NASDAQ:IAS) CEO Lisa Utzschneider sold 30,407 shares of the company’s stock in a transaction on Monday, April 8th. The stock was sold at an average price of $10.05, for a total transaction of $305,590.35. Following the sale, the chief executive officer now directly owns 188,678 shares of the company’s stock, valued at $1,896,213.90. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Lisa Utzschneider also recently made the following trade(s):

• On Tuesday, February 6th, Lisa Utzschneider sold 13,113 shares of Integral Ad Science stock. The shares were sold at an average price of $15.79, for a total transaction of $207,054.27.

Integral Ad Science Price Performance

IAS opened at $9.74 on Thursday. The firm has a market cap of $1.56 billion, a price-to-earnings ratio of 243.56, a price-to-earnings-growth ratio of 1.43 and a beta of 1.60. Integral Ad Science Holding Corp. has a fifty-two week low of $9.10 and a fifty-two week high of $20.88. The company’s 50-day moving average price is $12.16 and its 200 day moving average price is $13.15. The company has a quick ratio of 3.21, a current ratio of 3.21 and a debt-to-equity ratio of 0.17.

Integral Ad Science (NASDAQ:IAS) last released its quarterly earnings data on Tuesday, February 27th. The company reported $0.06 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.03. The firm had revenue of $134.30 million for the quarter, compared to analyst estimates of $131.27 million. Integral Ad Science had a net margin of 1.53% and a return on equity of 0.83%. Integral Ad Science’s quarterly revenue was up 14.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.07 earnings per share. As a group, sell-side analysts expect that Integral Ad Science Holding Corp. will post 0.2 earnings per share for the current year.

Institutional Investors Weigh In On Integral Ad Science

Institutional investors and hedge funds have recently bought and sold shares of the business. Ameritas Investment Partners Inc. increased its stake in shares of Integral Ad Science by 92.1% in the first quarter. Ameritas Investment Partners Inc. now owns 2,499 shares of the company’s stock valued at $34,000 after purchasing an additional 1,198 shares during the period. Skandinaviska Enskilda Banken AB publ acquired a new stake in shares of Integral Ad Science in the third quarter valued at approximately $58,000. DekaBank Deutsche Girozentrale acquired a new stake in shares of Integral Ad Science in the third quarter valued at approximately $62,000. Tower Research Capital LLC TRC increased its stake in shares of Integral Ad Science by 493.4% in the third quarter. Tower Research Capital LLC TRC now owns 8,581 shares of the company’s stock valued at $62,000 after purchasing an additional 7,135 shares during the period. Finally, Amalgamated Bank increased its stake in shares of Integral Ad Science by 19.9% in the third quarter. Amalgamated Bank now owns 6,951 shares of the company’s stock valued at $83,000 after purchasing an additional 1,156 shares during the period. Institutional investors and hedge funds own 95.78% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on IAS shares. Raymond James cut shares of Integral Ad Science from a “strong-buy” rating to an “outperform” rating and decreased their price objective for the company from $20.00 to $16.00 in a research report on Wednesday, February 28th. Piper Sandler decreased their price objective on shares of Integral Ad Science from $20.00 to $18.00 and set an “overweight” rating for the company in a research report on Wednesday, February 28th. Oppenheimer decreased their price objective on shares of Integral Ad Science from $25.00 to $20.00 and set an “outperform” rating for the company in a research report on Wednesday, February 28th. Barclays decreased their price objective on shares of Integral Ad Science from $17.00 to $16.00 and set an “equal weight” rating for the company in a research report on Wednesday, February 28th. Finally, Bank of America assumed coverage on shares of Integral Ad Science in a research report on Thursday, January 11th. They issued a “buy” rating and a $19.00 price objective for the company. Three equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to data from MarketBeat, Integral Ad Science has an average rating of “Moderate Buy” and a consensus target price of $18.29.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.